Myocyte Recovery After Mechanical Circulatory Support in Humans with End-stage Heart Failure
Overview
Affiliations
Background: The failing myocardium is characterized by decreased force production, slowed relaxation, and depressed responses to beta-adrenergic stimulation. In some heart failure patients, heart function is so poor that a left ventricular assist device (LVAD) is inserted as a bridge to transplantation. In the present research, we investigated whether circulatory support with an LVAD influenced the functional properties of myocytes from the failing heart.
Methods And Results: Myocytes were isolated from human explanted failing hearts (HF-myocytes) and failing hearts with antecedent LVAD support (HF-LVAD-myocytes). Studies of myocyte function indicated that the magnitude of contraction was greater (9.6+/-0.7% versus 6.9+/-0.5% shortening), the time to peak contraction was significantly abbreviated (0.37+/-0.01 versus 0.75+/-0.04 seconds), and the time to 50% relaxation was reduced (0.55+/-0.02 versus 1.45+/-0.11 seconds) in the HF-LVAD-myocytes compared with the HF-myocytes (P<0.05). The HF-LVAD-myocytes had larger contractions than the HF-myocytes at all frequencies of stimulation tested. The negative force-frequency relationship of the HF-myocytes was improved in HF-LVAD-myocytes but was not reversed. Responses to beta-adrenergic stimulation (by isoproterenol) were greater in HF-LVAD-myocytes versus HF-myocytes.
Conclusions: The results of the study strongly support the idea that circulatory support with an LVAD improves myocyte contractile properties and increases beta-adrenergic responsiveness.
Lazaropoulos M, Gibb A, Chapski D, Nair A, Reiter A, Roy R Nat Cardiovasc Res. 2024; 3(7):869-882.
PMID: 39196175 PMC: 11358007. DOI: 10.1038/s44161-024-00502-3.
Pamias-Lopez B, Ibrahim M, Pitoulis F Front Cardiovasc Med. 2023; 10:1212875.
PMID: 37600037 PMC: 10433771. DOI: 10.3389/fcvm.2023.1212875.
Drakos S, Badolia R, Makaju A, Kyriakopoulos C, Wever-Pinzon O, Tracy C Circulation. 2022; 147(5):409-424.
PMID: 36448446 PMC: 10062458. DOI: 10.1161/CIRCULATIONAHA.121.056600.
Myocardial recovery following durable left ventricular assist device support.
Rao V, Billia F JTCVS Open. 2022; 8:1-5.
PMID: 36004137 PMC: 9390417. DOI: 10.1016/j.xjon.2021.10.005.
Glutamine uptake and catabolism is required for myofibroblast formation and persistence.
Gibb A, Huynh A, Gaspar R, Ploesch T, Lombardi A, Lorkiewicz P J Mol Cell Cardiol. 2022; 172:78-89.
PMID: 35988357 PMC: 10486318. DOI: 10.1016/j.yjmcc.2022.08.002.